At present, the National Institute on Drug Abuse (NIDA) has a monopoly on the production of marijuana for legitimate medical and research purposes in the United States. Judge Bittner found this monopoly to be unjustified, since federal law clearly requires adequate competition in the manufacture of Schedule I and II substances. (See 21 U.S.C. § 823(a)(1); see also 21 C.F.R. § 1301.33(b).)